Q2. How many MPRAGEs were averaged before pre-processing?
For samples 1, 2, 3 and 5, 2-4 MPRAGEs were averaged before pre-processing to increase signalto-noise (SNR) and contrast-to-noise ratio (CNR).
Q3. What is the next step to increasing understanding of the mechanisms of brain aging?
Important next step to increased understanding of the mechanisms of brain aging will be to conduct large-scale, multi-modal imaging studies, combining e.g. volumetry, DTI and intensity/contrast measures (Fjell et al., 2008, Westlye et al., 2010b, a), as well as longitudinal studies with high density of measurements to examine the trajectories across age with regards to the critical phases proposed on the basis of the cross-sectional analyses.21
Q4. Why did the longitudinal and cross-sectional results differ?
Because the methods used to calculate longitudinal change and to fit the cross-sectional trajectories differ in important aspects, and the samples do not overlap, direct comparisons of estimations of absolute rates of atrophy between the longitudinal and cross-sectional results were not performed.
Q5. What is the point of maximum acceleration of slope change?
for quadratic models, the second derivative is assumed to be constant across the life span, and hence the point of maximum acceleration of slope change cannot be determined.
Q6. What is the approach to reproduce the dynamic process of change?
An ideal approach to reproduce the dynamic process of change would be longitudinal studies with high density of measures and assessment of multiple time windows across the life span (Raz et al., 2010; Raz & Lindenberger, 2011).
Q7. What is the algorithm for smoothing spline?
The authors used an algorithm that optimizes smoothing level based on a version of Bayesian Information Criterion (BIC), i.e. the smoothing level that minimizes BIC for each analysis was chosen.
Q8. What was the average volume of the brain in the cross-sectional data?
Brain volumes in the cross-sectional data were regressed on sample and ICV, and age-reductions estimated from the cross-sectional data were measured in standard deviation decline in volume in the age-range 60 to 90.
Q9. What is the structure that distinguishes between healthy and AD patients?
Even though hippocampal volume is the structure that distinguishes best between AD-patients and healthy elderly, amygdala is also affected in early stages of the disease (Fjell et al., 2010b).
Q10. What is the significance of the hippocampus in AD?
Hippocampus is especially important due to its role in memory and early AD (de Leon et al., 2006, Du et al., 2007, Jack et al., 2008, Fennema-Notestine et al., 2009, McEvoy et al., 2009).
Q11. What is the rank order of magnitude of the cross-sectional results?
at least in their rank order of magnitude, the cross-sectional results for the age-range above 60 years seem to be largely in coherence with independent longitudinal data.
Q12. How many major regions and structures were included in the study?
The authors included volume for 17 major regions and structures estimated from the whole-brain segmentation approach in FreeSurfer (Fischl et al., 2002).
Q13. What is the way to infer changes in brain volume?
It is impossible to infer changes in brain structures based on cross-sectional data alone (Raz and Lindenberger, 2010), as this depends on assumptions of no cohort-effects and selection18bias.
Q14. What were the critical ages for the structures that showed deviations from linearity?
For the structures that showed deviations from linearity (except putamen), critical ages, i.e. the ages where estimated atrophy started to accelerate or decelerate, were identified.
Q15. What was the way to test the stability of the results?
To test the stability of the results, a split half analysis was performed for WM volume (Supplementary Figure 2), yielding identical spline curves.
Q16. How did the authors calculate the slope of the local smoothing curve?
The authors calculated the ages where the slope of the local smoothing curve changed (the secondderivative), using the expression − d2 f age( )d age2 .